Dongcheng Pharmaceutical

Company Drug

Yantai Dongcheng Receives NMPA Approval for F18 PET Imaging Study

Fineline Cube Dec 22, 2022

China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) has announced receiving approval from the...

Company Deals

Yantai Dongcheng to Acquire US Firm XingImaging for $30.2M

Fineline Cube Dec 13, 2022

China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) is set to acquire a 100%...

Company Deals

Yantai Dongcheng Pharma Acquires Rights to 18F-APN-1607 from Aprinoia Therapeutics

Fineline Cube Dec 8, 2022

China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) announced the plan to acquire the...

Company Drug

Dongcheng Pharmaceutical Gets NMPA Green Light for PSMA PET Imaging Drug

Fineline Cube Aug 1, 2022

China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) announced it has received approval from...

Company Deals

Johnson & Johnson Completes Acquisition of Intra-Cellular Therapies

Company Deals Medical Device

Yuewei Medtech Secures RMB100 Million in Series A++ Funding for Cardiac Device Development

Company

Boehringer Ingelheim Reports 6.1% Sales Growth in 2024, Bolstered by Key Pharmaceuticals

Company Deals

GE Healthcare Partners with Probo Medical to Distribute Ultrasound Devices